MuSK Myasthenia 1000 Study

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
George Washington University
Study ID
NCT06259071
Status
Recruiting
Apply to this trial

Conditions

  • MuSK MG
  • MuSK Myasthenia Gravis
  • Myasthenia Gravis

Eligibility Criteria

Sex
ALL
Age
7 Years - 99 Years
Healthy Volunteers
Not accepted

Study Details

The MuSK myasthenia gravis 1000 study seeks to collect saliva samples from 1000 subjects with laboratory confirmed diagnosis of MuSK myasthenia to identify genetic variations associated with MuSK MG. The data collected may be used by researchers to gain a better understanding of the cause of MuSK MG and to identify biomarkers and targeted therapy for MuSK MG.

Key Dates

First listed
Feb 14, 2024
Start date
Aug 23, 2023
Status verified
Aug 2026
Primary completion
Aug 23, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

GWAS [ Time Frame: 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
George Washington UniversityWashington D.C.District of Columbia20037
Gulsen Oztosun, MD
[email protected]
202-677-6109

Find similar trials in Washington D.C., DC

By research site
George Washington University· Washington D.C., DC

Related Studies